Keating SJ - Search Results

1

Toward site-specific and self-sufficient robotic fabrication on architectural scales.

Keating SJ, Leland JC, Cai L, Oxman N. Keating SJ, et al. Sci Robot. 2017 Apr 26;2(5):eaam8986. doi: 10.1126/scirobotics.aam8986. Sci Robot. 2017. PMID: 33157892

2

3D Printed Multimaterial Microfluidic Valve.

Keating SJ, Gariboldi MI, Patrick WG, Sharma S, Kong DS, Oxman N. Keating SJ, et al. PLoS One. 2016 Aug 15;11(8):e0160624. doi: 10.1371/journal.pone.0160624. eCollection 2016. PLoS One. 2016. PMID: 27525809 Free PMC article.

3

DNA Assembly in 3D Printed Fluidics.

Patrick WG, Nielsen AA, Keating SJ, Levy TJ, Wang CW, Rivera JJ, Mondragón-Palomino O, Carr PA, Voigt CA, Oxman N, Kong DS. Patrick WG, et al. Among authors: keating sj. PLoS One. 2015 Dec 30;10(12):e0143636. doi: 10.1371/journal.pone.0143636. eCollection 2015. PLoS One. 2015. PMID: 26716448 Free PMC article.

4

Multi-scale thermal stability of a hard thermoplastic protein-based material.

Latza V, Guerette PA, Ding D, Amini S, Kumar A, Schmidt I, Keating S, Oxman N, Weaver JC, Fratzl P, Miserez A, Masic A. Latza V, et al. Nat Commun. 2015 Sep 21;6:8313. doi: 10.1038/ncomms9313. Nat Commun. 2015. PMID: 26387704 Free PMC article.

5

Treatment patterns and costs among US patients with diffuse large B-cell lymphoma not treated with 2L stem cell transplantation.

Acheampong T, Gu T, Le TK, Keating SJ. Acheampong T, et al. Among authors: keating sj. Future Oncol. 2024 Mar;20(10):623-634. doi: 10.2217/fon-2023-0385. Epub 2024 Jan 17. Future Oncol. 2024. PMID: 38230990 Free article.

6

Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia.

Klink AJ, Keating SJ, Brokars J, Feinberg B, Jabbour E. Klink AJ, et al. Among authors: keating sj. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):149-157. doi: 10.1016/j.clml.2023.10.005. Epub 2023 Oct 20. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38135632

7

Estimating the Cost per Clinical Outcome of Second-Line Liso-Cel Versus Autologous Stem Cell Transplantation in Patients with Transplantation-Intended Relapsed/Refractory Large B Cell Lymphoma.

Saeedian M, Badaracco J, Botros A, Gitlin M, Keating SJ. Saeedian M, et al. Among authors: keating sj. Transplant Cell Ther. 2023 Nov;29(11):712.e1-712.e7. doi: 10.1016/j.jtct.2023.08.001. Epub 2023 Aug 5. Transplant Cell Ther. 2023. PMID: 37544410 Free article.

8

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United States.

Parker C, Liu FF, Deger KA, Franco-Villalobos C, Proskorovsky I, Keating SJ, Sorensen S. Parker C, et al. Among authors: keating sj. Adv Ther. 2023 May;40(5):2355-2374. doi: 10.1007/s12325-023-02444-x. Epub 2023 Mar 22. Adv Ther. 2023. PMID: 36947328 Free PMC article.

9

A Model to Estimate Cytokine Release Syndrome and Neurological Event Management Costs Associated With CAR T-Cell Therapy.

Badaracco J, Gitlin M, Keating SJ. Badaracco J, et al. Among authors: keating sj. Transplant Cell Ther. 2023 Jan;29(1):59.e1-59.e6. doi: 10.1016/j.jtct.2022.10.009. Epub 2022 Oct 19. Transplant Cell Ther. 2023. PMID: 36272529 Free article.

10

Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United States.

Keating SJ, Gu T, Jun MP, McBride A. Keating SJ, et al. Transplant Cell Ther. 2022 Jul;28(7):404.e1-404.e6. doi: 10.1016/j.jtct.2022.03.021. Epub 2022 Mar 27. Transplant Cell Ther. 2022. PMID: 35354101 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters